The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease

Recruiting N/A Interventional Study
Atherosclerosis Stress Inflammation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
36 (estimated)
Sponsor
Massachusetts General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to evaluate the effect of 8 weeks of a stress reduction intervention on atherosclerotic plaque inflammation in adults with stable coronary artery disease, as quantified by positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in individuals with increased psychosocial stress.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Must admit to feeling stressed and/or have PSS score \> 13 (moderate stress) * Must be willing to complete stress reduction course and imaging sessions with \< 3 missed appointments in last year * Known clinical cardiovascular disease with prior atherosclerotic myocardial infa…
Contacts

Michael T Osborne, MD

6176432114

mosborne@mgh.harvard.edu

CONTACT